Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
57:46
March 10, 2026 - PBS News Hour full episode
56:46
March 9, 2026 - PBS News Hour full episode
57:46
March 6, 2026 - PBS News Hour full episode
57:46
March 5, 2026 - PBS News Hour full episode
57:46
March 4, 2026 - PBS News Hour full episode
57:46
March 3, 2026 - PBS News Hour full episode
57:46
March 2, 2026 - PBS News Hour full episode
57:46
February 27, 2026 - PBS News Hour full episode
57:46
February 26, 2026 - PBS News Hour full episode
57:46
February 25, 2026 - PBS News Hour full episode
57:46
February 24, 2026 - PBS News Hour full episode
57:46
February 23, 2026 - PBS News Hour full episode